Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
At this price it’s a strong buy,it’s just private investors trading around the edges, need volume to move share price which I think will happen with quarter 3 from next week and FDA news could drop any time and then the fun will begin! At this price people should be taking a position not trying to scalp 10% but each to their own.
Quarter 3!
Nice RNS, early Q3 could be next month! I think if low on funds TB I’ll just lend them the money, get FDA nA3 and sell for a 100million!
Good day, can move fast, Trevor give us some news for it to take off! It will be appreciated!
Something has to give here, hopefully a strong move upwards, would not be surprised if company is sold this year, with company IB more visible vis trade shows and FDA approval, so getting noticed for work / research being done and AI being the hot topic at the moment, all to play for, thing Kanes buy was well timed!
Having a nice day on director buying! Come on Trevor
That may be the case or not but cash position needs to be sorted out by July because based on last years accounts cash will run out if sales stay the same and expenditure does not decrease, I think when cash flow is sorted it will attract investors to start buying again but we are waiting TB, he needs to keep his promise per accounts in April, something will give soon give and my bet is it will be a upward move.
rnss have been sp****!
if you look at rnss over past 12months they have been sp****, trevor needs to keep his promise in annual report about driving up share price! we are now having a trickle of daily sells with bored shareholders looking elsewhere but trevor needs to give people a reason to invest that is visible, cash flow is still a concern if you look at last accounts heading into summer. iqai/ib are under capitalised for what they want to do over next couple of years, best to sell company to someone with enough cash or take on a partner but we are all hostage to trevor’s whims!
Thanks Trek but not sure what can be holdup any finance package/CLN if required at this share price, with the expansion in AI, IB are ideally placed but board need to communicate there plans or sell the company for 50p per share!
Trevor was to busy on the other site trolling shareholders of Feedback over bank holiday to get any news out for IQAI/IB!
Still waiting for the news that is under wraps per email to Trek over a month ago! Cash flow is still up in the air, to raise or not to raise!
Fingers and toes!
Well that news that they had to keep quiet about needs to get out! This is getting a bit silly, Trevor get your CLN done so sp can move up!
No rush to buy on such good news not RNS,d!
17th May, news before?
Trevor will support it but get it out of the way now! It’s just dragging on share price, 2023 looks to be a good year but what will move share price, hopefully upwards!
20th April 2020 share price 2.85p, 3 years later 2.6p, time for IQAI to start to deliver!
What’s next is results and shareholders quarterly letter, what else remains to be seen but funding is the key now. In an ideal world results would show cash flow positive and no need to raise funds, they had a research note last year which had projections for profit & loss and if comes to fruition then no need to raise! Low market cap and only 180million shares in issue with Trevor & board hold about £65million so all to play for.
Feel news has been kept to a minimum, orphan drug status should have been released at 7am not 3.52pm, it’s a uk listed company, we have no trades on US market! Think someone wants to keep this low until it’s suits them to let it rise, good weekend all
It appears every time we have a decent buy it is followed by a sell, see Thursday, or is it my paranoia!